Business Wire - Singulair Now Available For Children with Asthma as Young as 12 Months Old; New Oral Granules Formulation Offers Convenient, Once-A-Day Option
Thursday, September 25th, 2008 Business Editors/Health & Pharmaceutical Writers
WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Sept. 15, 2003
Merck & Co., Inc. announced today that SINGULAIR(R) (montelukast sodium) is now available by prescription in a new, convenient, once-a-day “oral granules” formulation.
SINGULAIR oral granules (4 mg) can be used once daily in the evening for the prevention and chronic treatment of asthma (Indications and Usage page 9 A) in children a…
